Rocket Lab posts $268 million quarter, expects Neutron in 2027

Rocket Lab reported Q3 2026 revenue of $267.8M, up 73% YoY, exceeding forecasts. Net loss widened to $79.7M, with adjusted EBITDA at -$18.0M. Space systems revenue grew 88% to $214.8M. Neutron rocket's launch delayed to 2027 due to manufacturing issues. Backlog reached $3.57B, with $1B in new launch contracts. Iridium acquisition pending regulatory approval, expected to close in 2027.

Original reporting
Published Nov 11, 2026, 9:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 11:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RKLB
Bullish
high confidence
Mentioned
$RKLB
Relevance
8/10
AlphAI data visualization · based on jspacenews.com
Decision brief

The 30-second read

$RKLBBullishHigh
01

Why it matters

The earnings beat may attract buying interest, but the loss expansion and product delay could offset gains, leading to a muted or slightly negative market reaction.

02

Market read

First-report earnings for a mid-cap space launch firm with material financial figures and operational updates, relevant for aerospace sector investors.

03

What to watch

The $1B of new launch contracts and a $515M Neutron contract backlog may provide longer-term upside not reflected in immediate price action.

Relevance 8/10Novelty 8/10Timing: after-hours today

Background

Rocket Lab's Q3 filing includes a higher-than-expected revenue number, a widened loss, and a delay of its flagship Neutron rocket to 2027 due to a tank issue.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Rocket Lab reported Q3 2026 revenue of $267.8M, a 73% YoY increase, but net loss widened to $79.7M and Neutron launch delayed to 2027.

Expected impact

likely modest downside as investors digest higher loss and launch delay

Evidence & confidence

Revenue topped guidance, yet widening loss and a key product delay introduce uncertainty, balancing the reaction.

Market effects

Space launch sector may see mixed sentiment; revenue growth supports demand, but Neutron delay could temper optimism.

U.S. small-cap aerospace stocks could experience slight pressure.

Limited to investors focused on commercial space and satellite services.

Counterpoint

Despite the loss widening, the strong order backlog and revenue beat could justify a short-term rally.

Key entities

  • Rocket Lab

    U.S.-listed aerospace launch provider (NASDAQ: RKLB).

Related articles

$RKLBMed

Could Rocket Lab Actually Climb 56%? Or Is Morgan Stanley Totally Wrong?

Morgan Stanley reduced its price target for Rocket Lab to $103, 56% above its Nov. 11 close of $66.15, while maintaining an Overweight rating. The company sold $2.4B in stock Q3 and delayed Neutron's first launch to 2027. Analysts expect 3 cents EPS for 2027, down from 16 cents a year ago. Rocket Lab reported record revenue of $268M, up 73%, but a wider GAAP loss of 12 cents per share.

$RKLBMedAI 8/10

$8 Billion Merger Stuck at FCC: SpaceX Accuses Iridium of Using Spectrum Objections to Block Starlink Ground Stations — BigGo Finance

Rocket Lab's $8B acquisition of Iridium Communications faces FCC review opposition from SpaceX, which claims Iridium's spectrum objections are anticompetitive. The deal, valued at $54 per share, is expected to close in 2027. SpaceX seeks to include Iridium's spectrum behavior in the FCC's public-interest assessment, while Rocket Lab and Iridium argue the merger is pro-competitive. The FCC must decide whether to consider spectrum disputes in merger reviews.

$RKLBHighAI 8/10

Rocket Lab CEO Says It Could Be ‘Extremely Profitable’ Without Neutron — But SpaceX Is Not The Only Reason It’s Building The Rocket

Rocket Lab CEO Peter Beck sees a $1 trillion market in space services, beyond the $10-20 billion launch market. The company's proposed $8 billion acquisition of Iridium Communications (IRDM) is expected to close in mid-2027. Neutron rocket's debut is delayed to 2027, with 16 flights booked, including 8 worth $515 million. RKLB stock is down 5% year-to-date, with mixed retail sentiment.

$RKLBMed

Rocket Lab Lands $150M OSC Loan Pledge for Neutron Rocket

Rocket Lab USA secured a conditional $150M loan from the Department of War's Office of Strategic Capital for its reusable Neutron rocket. Funds will expand production and add recovery vessels. The loan is subject to due diligence and other conditions. Neutron is designed to carry 13,000 kg to low Earth orbit, supporting satellite constellations and national security payloads. This is OSC's third $150M space-sector commitment.